LIVN Q3 2020 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q3 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$240M-10.6% YoY

Gross Profit

$143M59.5% margin

Operating Income

-$3M-1.3% margin

Net Income

-$15M-6.2% margin

EPS (Diluted)

$-0.30

QoQ Revenue Growth

+31.8%

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

-$2M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$1.2B

Stockholders' Equity

$1.4B

Cash & Equivalents

$228M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$240M	$269M	-10.6%
Gross Profit	$143M	$179M	-20.4%
Operating Income	-$3M	$26M	-112.6%
Net Income	-$15M	$32M	-146.0%

Revenue Segments

Cardiovascular Segment

$141M59%

Neuromodulation Segment

$98M41%

Geographic Segments

UNITED STATES

$129M54%

Locations Excluding The United States And Europe

$63M26%

Europe

$49M20%